MS patients in libya face delays in diagnosis and treatment, new study reveals
NCT ID NCT07264725
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at 369 adults with multiple sclerosis (MS) in Libya to understand how long it takes to get diagnosed, who receives advanced treatments, and how disability levels are affected. Researchers used data from a national MS registry at two hospitals. The goal is to identify gaps in care within a conflict-affected health system and suggest improvements.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could highlight specific barriers to MS diagnosis and treatment in conflict zones, guiding improvements in healthcare delivery for similar settings.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and findings may not apply to other countries or healthcare systems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tripoli University Hospital
Zintan, Libya
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?